Atlas Trials

First in Human Evaluation of Safety, Pharmacokinetics, and Clinical Activity of a Monoclonal Antibody Targeting Netrin 1 in Patients With Advanced/Metastatic Solid Tumors

Clinical trial NCT02977195 · COMPLETED

Trial details

NCT number
NCT02977195
Sponsor
Centre Leon Berard
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Solid TumorEndometrial CarcinomaHormone Receptor Positive
Start date
2017-01-09
Primary completion
2021-12-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.